179 related articles for article (PubMed ID: 11196511)
1. Abnormal responses to endothelial agonists in Raynaud's phenomenon and scleroderma.
Freedman RR; Girgis R; Mayes MD
J Rheumatol; 2001 Jan; 28(1):119-21. PubMed ID: 11196511
[TBL] [Abstract][Full Text] [Related]
2. Endothelial and adrenergic dysfunction in Raynaud's phenomenon and scleroderma.
Freedman RR; Girgis R; Mayes MD
J Rheumatol; 1999 Nov; 26(11):2386-8. PubMed ID: 10555897
[TBL] [Abstract][Full Text] [Related]
3. Digital iontophoresis of vasoactive substances as measured by laser Doppler imaging--a non-invasive technique by which to measure microvascular dysfunction in Raynaud's phenomenon.
Anderson ME; Moore TL; Lunt M; Herrick AL
Rheumatology (Oxford); 2004 Aug; 43(8):986-91. PubMed ID: 15199217
[TBL] [Abstract][Full Text] [Related]
4. Digital vascular responses to cooling in subjects with cold sensitivity, primary Raynaud's phenomenon, or scleroderma spectrum disorders.
Maricq HR; Weinrich MC; Valter I; Palesch YY; Maricq JG
J Rheumatol; 1996 Dec; 23(12):2068-78. PubMed ID: 8970043
[TBL] [Abstract][Full Text] [Related]
5. Enhanced cholinergic cutaneous vasodilation in Raynaud's phenomenon.
Khan F; Coffman JD
Circulation; 1994 Mar; 89(3):1183-8. PubMed ID: 8124805
[TBL] [Abstract][Full Text] [Related]
6. Maximum blood flow and microvascular regulatory responses in systemic sclerosis.
Gunawardena H; Harris ND; Carmichael C; McHugh NJ
Rheumatology (Oxford); 2007 Jul; 46(7):1079-82. PubMed ID: 17494087
[TBL] [Abstract][Full Text] [Related]
7. Skin blood flow in patients with systemic sclerosis and Raynaud's phenomenon: effects of oral L-arginine supplementation.
Khan F; Belch JJ
J Rheumatol; 1999 Nov; 26(11):2389-94. PubMed ID: 10555898
[TBL] [Abstract][Full Text] [Related]
8. Local hyperemia to heating is impaired in secondary Raynaud's phenomenon.
Boignard A; Salvat-Melis M; Carpentier PH; Minson CT; Grange L; Duc C; Sarrot-Reynauld F; Cracowski JL
Arthritis Res Ther; 2005; 7(5):R1103-12. PubMed ID: 16207327
[TBL] [Abstract][Full Text] [Related]
9. Non-invasive assessment of digital vascular reactivity in patients with primary Raynaud's phenonenon and systemic sclerosis.
Anderson ME; Campbell F; Hollis S; Moore T; Jayson MI; Herrick AL
Clin Exp Rheumatol; 1999; 17(1):49-54. PubMed ID: 10084032
[TBL] [Abstract][Full Text] [Related]
10. Cooling-induced contraction and protein tyrosine kinase activity of isolated arterioles in secondary Raynaud's phenomenon.
Furspan PB; Chatterjee S; Mayes MD; Freedman RR
Rheumatology (Oxford); 2005 Apr; 44(4):488-94. PubMed ID: 15695304
[TBL] [Abstract][Full Text] [Related]
11. Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.
Abou-Raya A; Abou-Raya S; Helmii M
J Rheumatol; 2008 Sep; 35(9):1801-8. PubMed ID: 18709692
[TBL] [Abstract][Full Text] [Related]
12. Digital pressure responses to cooling in patients with suspected early vs definite scleroderma (systemic sclerosis) vs primary Raynaud's phenomenon.
Maricq HR; Diat F; Weinrich MC; Maricq JG
J Rheumatol; 1994 Aug; 21(8):1472-6. PubMed ID: 7983649
[TBL] [Abstract][Full Text] [Related]
13. [Raynaud's syndrome: study of fingertip blood flow by plethysmography with venous occlusion (author's transl)].
Cristol R; Graisely B; Cloarec M; Debray J
Nouv Presse Med; 1979 Jan; 8(2):105-8. PubMed ID: 554069
[TBL] [Abstract][Full Text] [Related]
14. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy.
Fries R; Shariat K; von Wilmowsky H; Böhm M
Circulation; 2005 Nov; 112(19):2980-5. PubMed ID: 16275885
[TBL] [Abstract][Full Text] [Related]
15. Laser Doppler-recorded venoarteriolar reflex in Raynaud's phenomenon.
Stoyneva Z
Auton Neurosci; 2004 Nov; 116(1-2):62-8. PubMed ID: 15556839
[TBL] [Abstract][Full Text] [Related]
16. Ascorbic acid does not improve endothelium-dependent flow-mediated dilatation of the brachial artery in patients with Raynaud's phenomenon secondary to systemic sclerosis.
Mavrikakis ME; Lekakis JP; Papamichael CM; Stamatelopoulos KS; Kostopoulos ChC; Stamatelopoulos SF
Int J Vitam Nutr Res; 2003 Feb; 73(1):3-7. PubMed ID: 12690904
[TBL] [Abstract][Full Text] [Related]
17. Blood flow through the brachial artery at different temperatures in patients with Raynaud's phenomenon.
Savin E; Kedra W; Oliva I; Prerovský I; Martineaud JP
Cor Vasa; 1989; 31(4):299-305. PubMed ID: 2805704
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of bradykinin-induced tissue plasminogen activator release by angiotensin-converting enzyme inhibition.
Labinjoh C; Newby DE; Pellegrini MP; Johnston NR; Boon NA; Webb DJ
J Am Coll Cardiol; 2001 Nov; 38(5):1402-8. PubMed ID: 11691515
[TBL] [Abstract][Full Text] [Related]
19. Role of the endothelium on vasoactive agents in patients with liver cirrhosis.
Battaglia S; Angus P; Chin-Dusting JP
J Gastroenterol Hepatol; 2006 Jul; 21(7):1189-93. PubMed ID: 16824074
[TBL] [Abstract][Full Text] [Related]
20. [Digital blood flow measurement by venous occlusion plethysmography in Raynaud's phenomenon. Value of the rewarming test].
Cristol R; Debray J
J Mal Vasc; 1986; 11(1):85-9. PubMed ID: 3944527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
